Simcere Pharma

Nanjing, China Founded: 1995 • Age: 31 yrs
Novel oncology and immunology therapeutics are developed and commercialized.
Request Access

About Simcere Pharma

Simcere Pharma is a company based in Nanjing (China) founded in 1995.. The company has 6,580 employees as of December 31, 2024. Simcere Pharma offers products and services including Anti-tumor Drugs and Nervous System Drugs.

  • Headquarter Nanjing, China
  • Employees 6580 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Simcere Pharmaceutical Group Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $925.77 M (USD)
    -1.47
    as on Dec 31, 2024
  • Net Profit
    $102.35 M (USD)
    0.65
    as on Dec 31, 2024
  • EBITDA
    $171.25 M (USD)
    40.45
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    6580

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Simcere Pharma

Simcere Pharma is a publicly listed company on the HKEX with ticker symbol 2096 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: HKEX · Ticker: 2096 . Sector: Health technology · Hong Kong

Products & Services of Simcere Pharma

Simcere Pharma offers a comprehensive portfolio of products and services, including Anti-tumor Drugs and Nervous System Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Anti-tumor drugs are developed and marketed by Simcere for various cancer treatments.

Nervous system drugs are provided by Simcere for conditions like insomnia and related disorders.

People of Simcere Pharma
Headcount 1000-5000
Employee Profiles 27
Employee Profiles
People
Iris Gao
Manager & Executive Assistant To Cho/executive Director
People
Stewart Leung
Senior Director
People
Fiona Qiu
Director Of Finance
People
Vicky Fan
Talent Acquisition Manager

Unlock access to complete

Funding Insights of Simcere Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Simcere Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Simcere Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Simcere Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Simcere Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Simcere Pharma

Frequently Asked Questions about Simcere Pharma

When was Simcere Pharma founded?

Simcere Pharma was founded in 1995.

Where is Simcere Pharma located?

Simcere Pharma is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.

How many employees does Simcere Pharma have?

As of Dec 31, 2024, the latest employee count at Simcere Pharma is 6,580.

What is the annual revenue of Simcere Pharma?

Annual revenue of Simcere Pharma is $925.77M as on Dec 31, 2024.

What does Simcere Pharma do?

Simcere Pharma was founded in 1995 and is headquartered in Nanjing, China, within the pharmaceutical sector. Research, development, and commercialization of treatments for cancer and autoimmune diseases are conducted. The pipeline features antibody-drug conjugates and biologics directed at disease-specific pathways. Manufacturing and distribution networks are maintained to support products, and research partnerships are formed to advance therapy timelines for patients.

What products or services does Simcere Pharma offer?

Simcere Pharma offers Anti-tumor Drugs and Nervous System Drugs.

Is Simcere Pharma publicly traded?

Yes, Simcere Pharma is publicly traded on HKEX under the ticker symbol 2096.

What is Simcere Pharma's ticker symbol?

The ticker symbol of Simcere Pharma is 2096 on HKEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available